EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer (vol 21, pg 151, 2020)

被引:2
|
作者
Burande, Ankita Sanjay [1 ]
Viswanadh, Matte Kasi [1 ]
Jha, Abhishek [1 ]
Mehata, Abhishesh Kumar [1 ]
Shaik, Azad [1 ]
Agrawal, Nishi [1 ]
Poddar, Suruchi [2 ]
Mahto, Sanjeev Kumar [2 ,3 ]
Muthu, Madaswamy S. [1 ,3 ]
机构
[1] Indian Inst Technol BHU, Dept Pharmaceut Engn & Technol, Varanasi 221005, Uttar Pradesh, India
[2] Indian Inst Technol BHU, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India
[3] Indian Inst Technol BHU, Ctr Biomat & Tissue Engn, Varanasi 221005, Uttar Pradesh, India
关键词
D O I
10.1208/s12249-020-01755-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As the authors were working on similar projects on liposomes at the same time, the 3D figures of Fig. 3 bi and Fig. 3 bii were inadvertently misplaced.
引用
收藏
页码:207 / 207
页数:1
相关论文
共 50 条
  • [41] New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells (vol 39, pg 241, 2020)
    Ciocan-Cartita, Cristina Alexandra
    Jurj, Ancuta
    Zanoaga, Oana
    Cojocneanu, Roxana
    Pop, Laura-Ancuta
    Moldovan, Alin
    Moldovan, Cristian
    Zimta, Alina Andreea
    Raduly, Lajos
    Pop-Bica, Cecilia
    Buse, Mihail
    Budisan, Liviuta
    Virag, Piroska
    Irimie, Alexandru
    Gomes Dias, Sandra Martha
    Berindan-Neagoe, Ioana
    Braicu, Cornelia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [42] MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer (vol 134, pg 2424, 2014)
    Kim, Y. J.
    Choi, H-S
    Seo, J.
    Song, J-Y
    Lee, S. E.
    Kwon, M. J.
    Kwon, M. J.
    Kundu, J.
    Jung, K.
    Oh, E.
    Shin, Y. K.
    Choi, Y-L
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (07) : E6 - E6
  • [43] Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells
    Gote, Vrinda
    Sharma, Amar Deep
    Pal, Dhananjay
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 35
  • [44] HA-modified mesoporous Silica/hydroxyapatite hybrid targeted nanoparticles loaded with cabazitaxel and LY294002 for enhanced treatment of triple-negative breast cancer
    Liu, Songlin
    Shao, Xinzhe
    Wang, Hui
    Chu, Xinlei
    Yang, Wenjia
    Yao, Qingqiang
    Zhang, Pingping
    MATERIALS LETTERS, 2024, 371
  • [45] Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype (vol 6, pg 23216, 2016)
    He, Qing
    Jing, Hongyu
    Liaw, Lucy
    Gower, Lindsey
    Vary, Calvin
    Hua, Shucheng
    Yang, Xuehui
    SCIENTIFIC REPORTS, 2017, 7
  • [46] Triple-negative breast cancer suppressive activities, antioxidants and pharmacophore model of new acylated rhamnopyranoses from Premna odorata (vol 10, pg 10584, 2020)
    Elmaidomy, Abeer H.
    Mohammed, Rabab
    Owis, Asmaa I.
    Hetta, Mona H.
    AboulMagd, Asmaa M.
    Siddique, Abu Bakar
    Abdelmohsen, Usama Ramadan
    Rateb, Mostafa E.
    El Sayed, Khalid A.
    Hassan, Hossam M.
    RSC ADVANCES, 2021, 11 (08) : 4373 - 4373
  • [47] TRIPLE NEGATIVE BREAST CANCER - CURRENT STATUS AND PROSPECTIVE TARGETED TREATMENT BASED ON HER1 (EGFR), TOP2A AND C-MYC GENE ASSESSMENT
    Bouchalova, Katerina
    Cizkova, Magdalena
    Cwiertka, Karel
    Trojanec, Radek
    Hajduch, Marian
    BIOMEDICAL PAPERS-OLOMOUC, 2009, 153 (01): : 13 - 17
  • [48] Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model (vol 77, pg 204, 2019)
    Pal, Kunal
    Roy, Shubham
    Parida, Pravat Kumar
    Dutta, Ananya
    Bardhan, Souravi
    Das, Sukhen
    Jana, Kuladip
    Karmakar, Parimal
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 111
  • [49] TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer (vol 78, pg 489, 2018)
    Byrd, T.
    Fousek, K.
    Pignata, A.
    Szot, C.
    Samaha, H.
    Seaman, S.
    CANCER RESEARCH, 2018, 78 (12) : 3403 - 3403